EUVIMEDEUVIMED entdecken
Open Access · CC BY 2.0

Edaravone Dexborneol regulates the endothelial PPARγ-PON1 axis to inhibit high-cholesterol-induced atherosclerosis

Fengming Guo, Yuxin Liu, Wenjun Qiu, Xueyu Han, Yipeng Gao, Xin Liu, Sihui Huang, Jingjun Lv, Qi-Zhu Tang, Bo Yang, Bo Shen iD

Clinical Science · 12.08.2026 · 140 (8) · 1653-1673

DOI: 10.1042/cs20260830 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, online erschienen am 16.07.2026. Verfasst von Fengming Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, PR China. Hauptthemen laut MEDLINE: PPAR gamma, Atherosclerosis, Edaravone, Aryldialkylphosphatase. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: Hubei Provincial Key Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis, a primary cause of ischemic diseases, is driven by excessive oxidative stress. Edaravone Dexborneol, a clinically used antioxidant, has demonstrated potent protective effects in cerebral ischemia. However, its role in atherosclerosis remains unexplored. In the present study, atherosclerosis models were constructed using Apoe−/− mice fed a high-fat diet. Edaravone Dexborneol treatment significantly attenuated aortic atherosclerosis progression, evidenced by reduced advanced plaque burden and improved hemodynamic parameters at the aortic root. The treatment also suppressed oxidative stress, leading to decreased low-density lipoprotein (LDL) oxidation and reduced oxidized LDL accumulation in aortic tissues and endothelial cells. Mechanistically, RNA sequencing and Western blot analyses revealed that Edaravone Dexborneol alleviates oxidative damage by activating peroxisome proliferator-activated receptor gamma (PPARγ) and up-regulating paraoxonase 1 (PON1) expression. In human umbilical vein endothelial cells, PON1 knockdown partially abolished the antioxidant effects of Edaravone Dexborneol, while PPARγ inhibition reversed its induction of PON1. Furthermore, the combination of Edaravone Dexborneol with rosuvastatin exhibited synergistic anti-atherogenic effects superior to rosuvastatin alone. In conclusion, Edaravone Dexborneol attenuates atherosclerosis via the PPARγ/PON1 pathway, highlighting its potential as an antioxidant-based therapeutic strategy for atherosclerotic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PPAR gammaAtherosclerosisEdaravoneAryldialkylphosphataseCholesterolAntioxidantsAnimalsHumansOxidative StressHuman Umbilical Vein Endothelial CellsMice, Knockout, ApoEMaleMice, Inbred C57BLSignal TransductionMicePPAR-gamma AgonistsDiet, High-FatDisease Models, AnimalLipoproteins, LDL

Stichwörter der Autor:innen

Edaravone DexborneolPON1PPARγatherosclerosisendothelial dysfunctionoxidative stress

Substanzen

PPAR gammaEdaravoneAryldialkylphosphatasePON1 protein, mouseCholesterolAntioxidantsPparg protein, mousePPAR-gamma AgonistsLipoproteins, LDL

Autor:innen und Institutionen

  • Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, PR China.
  • Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan, PR China.
  • Department of Emergency, Renmin Hospital of Wuhan University, Wuhan, PR China.
  • State Key Laboratory of Neurology and Oncology Drug Development, Nanjing, PR China.

ORCID-Profile: Bo Shen

Förderung

  • Hubei Provincial Key Research and Development Program

Zitieren

APA

Guo, F., Liu, Y., Qiu, W., Han, X., Gao, Y., Liu, X., Huang, S., Lv, J., Tang, Q. Z., Yang, B., & Shen, B. (2026). Edaravone Dexborneol regulates the endothelial PPARγ-PON1 axis to inhibit high-cholesterol-induced atherosclerosis. Clinical Science, 140(8), 1653-1673. https://doi.org/10.1042/cs20260830

Vancouver

Guo F, Liu Y, Qiu W, Han X, Gao Y, Liu X, et al. Edaravone Dexborneol regulates the endothelial PPARγ-PON1 axis to inhibit high-cholesterol-induced atherosclerosis. Clinical Science. 2026;140(8):1653-1673. doi:10.1042/cs20260830

BibTeX
@article{Guo2026,
  author = {Guo, Fengming and Liu, Yuxin and Qiu, Wenjun and Han, Xueyu and Gao, Yipeng and Liu, Xin and Huang, Sihui and Lv, Jingjun and Tang, Qi-Zhu and Yang, Bo and Shen, Bo},
  title = {Edaravone Dexborneol regulates the endothelial PPARγ-PON1 axis to inhibit high-cholesterol-induced atherosclerosis},
  journal = {Clinical Science},
  year = {2026},
  volume = {140},
  number = {8},
  pages = {1653--1673},
  doi = {10.1042/cs20260830}
}
Kostenlos starten →